Systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse modelsMartine Latta‐Mahieu, Laurent Pradier, Alexis Bretteville et al.|Glia|2017Cited by 63